首頁 > 市場調查報告書 > 醫療設備

神經復健設備市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1898669

神經復健設備市場規模、佔有率和成長分析（按類型、應用、最終用戶和地區分類）—2026-2033年產業預測

Neurorehabilitation Devices Market Size, Share, and Growth Analysis, By Type (Neuro-Robotic Devices, Non-Invasive Stimulators), By Application (Brain Stroke, Parkinson's Disease), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，神經復健設備市場規模將達到 17.3 億美元，到 2025 年將達到 18.8 億美元，到 2033 年將達到 35.8 億美元，預測期（2026-2033 年）的複合年成長率為 8.4%。

神經復健設備市場正隨著人們對有效治療方法神經系統疾病（例如中風、多發性硬化症和帕金森氏症）的需求不斷成長而不斷發展，而這種需求的成長又受到人口老齡化和生活方式改變導致的患病率上升的推動。這種需求凸顯了對創新解決方案的迫切需求，這些解決方案能夠促進復原、改善功能能力，並提供個人化治療，幫助患者重獲獨立生活能力。市場面臨許多挑戰，例如需要持續研究以提高設備的有效性和易用性。然而，人工智慧和機器人等技術的進步為改善神經復健效果提供了巨大的機會。但是，將這些創新成果整合到臨床實踐中需要進行深入的研究並獲得監管部門的核准。儘管高昂的成本和嚴格的報銷政策構成挑戰，但擴大神經復健服務覆蓋範圍的前景仍然光明。

神經復健設備市場促進因素

神經復健設備市場主要由持續的技術創新所驅動。機器人、虛擬實境、穿戴式感測器和腦機介面等領域的創新正推動著更先進、更有效的神經復健工具的研發。這些最尖端科技能夠實現更個人化的治療和復健體驗。例如，先進的機器人外骨骼旨在幫助行動不便者改善行走和運動技能。持續的技術進步正在推動創新解決方案的開發，這些方案有望顯著改善患者的康復過程。

神經復健設備市場的限制因素

神經復健設備市場面臨的主要限制因素是這些技術相關的高成本。諸如機器人技術和腦機介面最尖端科技往往會推高設備價格。此外，操作這些先進設備所需的專業知識也會增加整體治療成本。因此，這種經濟障礙可能會限制神經復健設備的普及，尤其是在醫療資源有限或保險覆蓋不足的地區。這些經濟挑戰可能會阻礙這些關鍵復健方案的廣泛應用，進而影響真正需要的患者。

神經復健設備市場趨勢

神經復健設備市場正呈現出向遠距復健解決方案融合的顯著趨勢。這種創新方法使患者能夠遠端參與復健治療，並利用先進技術與醫療專業人員進行即時互動。遠距復健提高了便利性和可及性，使患者能夠在舒適的家中參與治療。它還有助於持續監測和個人化護理，從而改善治療效果。這種轉變不僅解決了傳統面對面復健的難題，而且鼓勵更多患者獲得所需的治療，從而推動了神經復健設備在醫療保健生態系統中的成長和普及。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Medtronic（US）
Abbott Laboratories（US）
Boston Scientific Corporation（US）
Stryker Corporation（US）
Smith & Nephew plc（UK）
Ekso Bionics Holdings, Inc.（US）
Bioxtreme Robotics Rehabilitation（Italy）
ReWalk Robotics Ltd.（Israel）
Neurostyle Pte. Ltd.（Singapore）
Kinova Robotics（Canada）
Neuro Rehab VR（US）
Tyromotion GmbH（Austria）
Neofect（South Korea）
Enraf-Nonius（Netherlands）
Hobbs Rehabilitation（UK）
Motek Medical BV（Netherlands）

結論與建議

簡介目錄

Product Code: SQMIG35A2377

Neurorehabilitation Devices Market size was valued at USD 1.73 Billion in 2024 and is poised to grow from USD 1.88 Billion in 2025 to USD 3.58 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The neurorehabilitation devices market is evolving in response to the increasing demand for effective interventions for neurological conditions like stroke, multiple sclerosis, and Parkinson's disease, driven by rising prevalence due to an aging population and lifestyle changes. This demand highlights the necessity for innovative solutions that facilitate recovery and improved functional abilities, offering patients personalized therapies to regain independence. While the market faces challenges, including the need for ongoing research to enhance device effectiveness and usability, technological advancements like artificial intelligence and robotics provide significant opportunities for improving neurorehabilitation outcomes. However, integrating these innovations into clinical practice requires thorough research and regulatory approval. Despite high costs and limited reimbursement policies posing challenges, opportunities for expanding accessibility to neurorehabilitation services remain promising.

Top-down and bottom-up approaches were used to estimate and validate the size of the Neurorehabilitation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Neurorehabilitation Devices Market Segments Analysis

Global Neurorehabilitation Devices Market is segmented by Type, Application, End User and region. Based on Type, the market is segmented into Neuro-Robotic Devices, Non-Invasive Stimulators and Brain-Computer Interfaces. Based on Application, the market is segmented into Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy and Others. Based on End User, the market is segmented into Rehabilitation Centers, Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Neurorehabilitation Devices Market

The neurorehabilitation devices market is significantly driven by ongoing technological advancements. Innovations in fields such as robotics, virtual reality, wearable sensors, and brain-computer interfaces have led to the creation of more advanced and effective neurorehabilitation tools. These cutting-edge developments facilitate the delivery of tailored therapies and personalized rehabilitation experiences for patients. For instance, sophisticated robotic exoskeletons are designed to aid individuals with mobility challenges, enhancing their ability to walk and improving motor skills. As technology continues to evolve, it fosters the development of innovative solutions that hold great promise for enhancing the rehabilitation journey of patients.

Restraints in the Neurorehabilitation Devices Market

A significant limitation in the neurorehabilitation devices market is the substantial expense linked to these technologies. Cutting-edge innovations, including robotics and brain-computer interfaces, often drive up the price of these devices. Furthermore, the need for specialized knowledge to operate these advanced tools can add to the overall treatment costs. As a result, this financial barrier may restrict access to neurorehabilitation devices, especially in areas where healthcare resources are scarce or insurance coverage is insufficient. Such economic challenges can impede the widespread adoption and use of these crucial rehabilitation solutions for patients in need.

Market Trends of the Neurorehabilitation Devices Market

The neurorehabilitation devices market is witnessing a significant trend towards the integration of tele-rehabilitation solutions. This innovative approach enables patients to engage in rehabilitation remotely, leveraging advanced technologies to facilitate real-time interactions with healthcare professionals. Tele-rehabilitation enhances convenience and accessibility, allowing patients to participate in therapy sessions from the comfort of their homes. Moreover, it fosters continuous monitoring and personalized care, improving treatment outcomes. This shift not only addresses the challenges posed by traditional in-person rehabilitation but also encourages more patients to pursue necessary therapy, thus driving the growth and adoption of neurorehabilitation devices in the healthcare ecosystem.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Neurorehabilitation Devices Market Size by Type & CAGR (2026-2033)

Market Overview
Neuro-Robotic Devices
Non-Invasive Stimulators
Brain-Computer Interfaces

Global Neurorehabilitation Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Brain Stroke
Parkinson's Disease
Multiple Sclerosis
Spinal Cord Injury
Traumatic Brain Injury
Cerebral Palsy
Others

Global Neurorehabilitation Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Rehabilitation Centers
Hospitals
Clinics

Global Neurorehabilitation Devices Market Size & CAGR (2026-2033)

North America (Type, Application, End User)
- US
- Canada
Europe (Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ekso Bionics Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioxtreme Robotics Rehabilitation (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReWalk Robotics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurostyle Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kinova Robotics (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuro Rehab VR (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tyromotion GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neofect (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enraf-Nonius (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hobbs Rehabilitation (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Motek Medical B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments